‘Prevalence, experience and awareness of substandard and falsified medicines among the public and healthcare professionals in Jordan’
Introduction This study aimed to assess the awareness, experiences and perspectives on substandard and falsified (SF) medicines among the general public and healthcare professionals in Jordan. SF medicines pose a global public health concern, yet data on their prevalence and associated risks in Jord...
Saved in:
| Main Authors: | Maysa M Falah, Eman Daar, Daniel Zahra, Michael James Dillon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-05-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/10/5/e018189.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists
by: Veronika J Wirtz, et al.
Published: (2019-07-01) -
Combatting substandard and falsified medicines: a view from Rwanda.
by: Agnes Binagwaho, et al.
Published: (2013-01-01) -
Substandard and Falsified Medical Products: Time to Arrest Their Growth
by: Saurabh RamBihariLal Shrivastava, et al.
Published: (2023-07-01) -
Combating substandard and falsified medicines in China: policy barriers and the role of pharmaceutical track-and-trace systems
by: Tangsiwei Xin
Published: (2025-12-01) -
Mobile apps for detecting falsified and substandard drugs: A systematic review.
by: Agustín Ciapponi, et al.
Published: (2021-01-01)